ALEXANDRIA, Va., July 20 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'RALSMI' in its latest official gazette. The trademark application with the serial number 99672403 was filed on Feb. 26, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): United Therapeutics Corporation 1000 Spring Street Silver Spring MD Maryland 20910 3 CORPORATION
Disclaimer: Curated by HT Syndication....